{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.questionFirstMinisteriallyCorrected.=2016-03-01T17%3A55%3A31.107Z&AnsweringBody.=Department+of+Health&min-answer.questionFirstAnswered.=2016-01-11T17%3A09%3A48.263Z&min-ddpModified.=2016-03-11T10%3A23%3A02.720Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?min-answer.questionFirstMinisteriallyCorrected.=2016-03-01T17%3A55%3A31.107Z&AnsweringBody.=Department+of+Health&min-answer.questionFirstAnswered.=2016-01-11T17%3A09%3A48.263Z&min-ddpModified.=2016-03-11T10%3A23%3A02.720Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.questionFirstMinisteriallyCorrected.=2016-03-01T17%3A55%3A31.107Z&AnsweringBody.=Department+of+Health&min-answer.questionFirstAnswered.=2016-01-11T17%3A09%3A48.263Z&_metadata=all&min-ddpModified.=2016-03-11T10%3A23%3A02.720Z", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&min-answer.questionFirstMinisteriallyCorrected.=2016-03-01T17%3A55%3A31.107Z&AnsweringBody.=Department+of+Health&min-answer.questionFirstAnswered.=2016-01-11T17%3A09%3A48.263Z&min-ddpModified.=2016-03-11T10%3A23%3A02.720Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.questionFirstMinisteriallyCorrected.=2016-03-01T17%3A55%3A31.107Z&AnsweringBody.=Department+of+Health&min-answer.questionFirstAnswered.=2016-01-11T17%3A09%3A48.263Z&min-ddpModified.=2016-03-11T10%3A23%3A02.720Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.questionFirstMinisteriallyCorrected.=2016-03-01T17%3A55%3A31.107Z&AnsweringBody.=Department+of+Health&min-answer.questionFirstAnswered.=2016-01-11T17%3A09%3A48.263Z&min-ddpModified.=2016-03-11T10%3A23%3A02.720Z", "items" : [{"_about" : "http://data.parliament.uk/resources/802162", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/802162/answer", "answerText" : {"_value" : "
The seven day services self-assessment survey completed by trusts in March 2017 included information on the availability of clinical interventions, including interventional radiology (IR), on a seven day basis for patients admitted to hospital in an emergency. The data showed that 72.30%<\/ins> <\/p> Information on the twice yearly collection is available on the NHS England website at:<\/p> https://www.england.nhs.uk/seven-day-hospital-services/progress<\/a><\/p> National Health Service regions have access to this report and will be able to consider any variation.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1542", "label" : {"_value" : "Biography information for Philip Dunne"}
}
, "answeringMemberConstituency" : {"_value" : "Ludlow"}
, "answeringMemberPrinted" : {"_value" : "Mr Philip Dunne"}
, "dateOfAnswer" : {"_value" : "2017-12-11", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/802162/answer/previousversion/28792", "answeringMember" : {"_about" : "http://data.parliament.uk/members/1542", "label" : {"_value" : "Biography information for Philip Dunne"}
}
, "answeringMemberConstituency" : {"_value" : "Ludlow"}
, "answeringMemberPrinted" : {"_value" : "Mr Philip Dunne"}
}
, "questionFirstAnswered" : [{"_value" : "2017-12-11T17:57:45.17Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2018-01-26T14:08:27.71Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-12-06", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Radiology"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what assessment he has made of the NHS\u2019 capacity to deliver 24-hour interventional radiology (image-guided surgery) services in each region.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/298", "label" : {"_value" : "Biography information for Steve McCabe"}
}
, "tablingMemberConstituency" : {"_value" : "Birmingham, Selly Oak"}
, "tablingMemberPrinted" : [{"_value" : "Steve McCabe"}
], "uin" : "117849"}
, {"_about" : "http://data.parliament.uk/resources/797514", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/797514/answer", "answerText" : {"_value" : " <\/p> NHS England is not responsible for approving medicines. The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring that medicines and medical devices work and are acceptably safe. The National Institute for Health and Care Excellence makes recommendations for the National Health Service on whether medicines and other treatments represent a clinically and cost effective use of NHS resources.<\/ins><\/p> <\/strong><\/ins><\/p> A list of medicines licensed by the MHRA for the treatment of thyroid conditions is attached. The list is split into two sections because thyroid conditions can be split into either those associated with an overactive thyroid (hyperthyroidism), or an underactive thyroid (hypothyroidism). The list contains only those medicines licensed for overactive and underactive thyroid. It should be noted that not all of the medicines listed will be available on the market at any one time. <\/ins><\/p><\/ins><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "attachment" : {"_about" : "http://data.parliament.uk/resources/797514/answer/attachment/1", "fileName" : {"_value" : "2017 12 06 Thyroid medicines formatted.xls"}
, "title" : "List of thyroid medicines"}
, "dateOfAnswer" : {"_value" : "2017-12-07", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/797514/answer/previousversion/27995", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
}
, "questionFirstAnswered" : [{"_value" : "2017-12-07T15:27:25.543Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2017-12-07T18:20:31.313Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-11-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Thyroid Gland: Diseases"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what medicines NHS England has approved for patients with thyroid conditions", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4478", "label" : {"_value" : "Biography information for Royston Smith"}
}
, "tablingMemberConstituency" : {"_value" : "Southampton, Itchen"}
, "tablingMemberPrinted" : [{"_value" : "Royston Smith"}
], "uin" : "116477"}
, {"_about" : "http://data.parliament.uk/resources/789103", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/789103/answer", "answerText" : {"_value" : " Since 2013, NHS England has been responsible for commissioning healthcare in all prisons in England. However, there are five prisons where primary healthcare services are commissioned by the Ministry of Justice (MOJ). In these five prisons some secondary healthcare services, including substance misuse and mental health, are commissioned by NHS England.<\/p> <\/p> Local Health Boards are responsible for commissioning healthcare services in public sector prisons in Wales.<\/p> <\/p> NHS England and the MOJ have provided the information in the attached table, which lists the healthcare provider for each prison in England and Wales.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"}
}
, "answeringMemberConstituency" : {"_value" : "Thurrock"}
, "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"}
, "attachment" : {"_about" : "http://data.parliament.uk/resources/789103/answer/attachment/1", "fileName" : {"_value" : "Revised PQ 113023 data table.docx"}
, "title" : "Commissioned Health providers for prisons"}
, "dateOfAnswer" : {"_value" : "2017-11-20", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/789103/answer/previousversion/23550", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"}
}
, "answeringMemberConstituency" : {"_value" : "Thurrock"}
, "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"}
, "attachment" : {"_about" : "http://data.parliament.uk/resources/789103/answer/previousversion/23550/attachment/1", "fileName" : {"_value" : "PQ113023 data table.docx"}
, "title" : "PQ113023 attached table"}
}
, "questionFirstAnswered" : [{"_value" : "2017-11-20T15:53:27.817Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2017-12-01T15:30:02.237Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-11-14", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Health Services: Prisons"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, if he will publish the name of the commissioned provider for health services in each prison in England and Wales.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4666", "label" : {"_value" : "Biography information for Dr Paul Williams"}
}
, "tablingMemberConstituency" : {"_value" : "Stockton South"}
, "tablingMemberPrinted" : [{"_value" : "Dr Paul Williams"}
], "uin" : "113023"}
, {"_about" : "http://data.parliament.uk/resources/782158", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/782158/answer", "answerText" : {"_value" : " In the past 10 years, the Department has paid Action on Smoking and Health (ASH) a total of £16,016.40 in non-grant funding for help in implementing additional strategies targeted at tackling health inequalities.<\/p> <\/p> Grant funding has also been given to ASH as in the attached table <\/ins> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "attachment" : {"_about" : "http://data.parliament.uk/resources/782158/answer/attachment/1", "fileName" : {"_value" : "Grant Funding to Action on Smoking and Health.docx"}
, "title" : "Grant Funding to ASH"}
, "dateOfAnswer" : {"_value" : "2017-11-06", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/782158/answer/previousversion/20537", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
}
, "questionFirstAnswered" : [{"_value" : "2017-11-06T17:30:52.563Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2017-11-08T10:47:05.703Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-11-01", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Action On Smoking and Health"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, pursuant to the Answer of 4 September 2017 to Question 6854, whether his Department has provided funding from non-section 64 sources to the organisation Action on Smoking and Health in the 2017-18 financial year or any of the last 10 financial years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1537", "label" : {"_value" : "Biography information for Mr Philip Hollobone"}
}
, "tablingMemberConstituency" : {"_value" : "Kettering"}
, "tablingMemberPrinted" : [{"_value" : "Mr Philip Hollobone"}
], "uin" : "110843"}
, {"_about" : "http://data.parliament.uk/resources/778216", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/778216/answer", "answerText" : {"_value" : " The Standardised Packaging of Tobacco Products Regulations 2015 came into force on 20 May 2016. The Government consulted on the introduction of standardised packaging and published an impact assessment, which included benefits to public health. The Government will review these regulations by 2021<\/ins> The table below shows the top five individual medicines For any medicine listed, it does not necessarily mean that the price has increased. For example, the cost per prescription item will be higher if the quantity being prescribed per prescription item has increased.<\/ins><\/p> This is based on Prescription Cost Analysis (PCA) data. PCA data is based on analysis of all prescriptions dispensed in the community i.e. by community pharmacists and appliance contractors, dispensing doctors, and prescriptions submitted by prescribing doctors for items personally administered in England. PCA data do not cover drugs dispensed in hospitals, including mental health trusts, or private prescriptions.<\/p> <\/p> Costs vary over time due to numerous factors including medicines going off patent and becoming available generically, unlicensed medicines becoming licensed medicines, shortages, the level of competition for generic medicines, as well as centrally agreed pricing schemes such as the Pharmaceutical Price Regulation Scheme.<\/p> <\/p> The Department is working closely with the Competition and Markets Authority on a number of investigations into unwarranted price rises of unbranded generic medicines. Where companies have breached competition law, we will seek damages and invest that money back into the National Health Service.<\/p> <\/p> The top five medicines with the highest increase in Net Ingredient1<\/sup> Cost per prescription item2<\/sup><\/p><\/td><\/tr> Drug Name<\/p><\/td> 2006<\/p><\/td> 2016<\/p><\/td> Increase<\/p><\/td><\/tr> Orfadin_Cap 10mg<\/p><\/td> £5,436.74<\/p><\/td> £20,030.86<\/p><\/td> £14,594.12<\/p><\/td><\/tr> Cerezyme_I/V Inf 400u Vl (Dry)<\/p><\/td> £18,143.17<\/p><\/td> £30,397.85<\/p><\/td> £12,254.68<\/p><\/td><\/tr> Chenodeoxycholic Acid_Cap 250mg<\/p><\/td> £88.57<\/p><\/td> £9,580.10<\/p><\/td> £9,491.54<\/p><\/td><\/tr> Trientine Dihydroch_Cap 300mg (Old)<\/p><\/td> £218.58<\/p><\/td> £5,488.22<\/p><\/td> £5,269.64<\/p><\/td><\/tr> Sod Benz_Liq Spec 400mg/5ml<\/p><\/td> £361.95<\/p><\/td> £4,352.92<\/p><\/td> £3,990.96<\/p><\/td><\/tr><\/tbody><\/table> Source: Prescription Cost Analysis<\/p> <\/p> Notes:<\/p> <\/p> 1<\/sup>NIC is the basic cost of a drug. It does not take account of discounts, dispensing costs, fees or prescription charges income, so the amount the NHS spent will be slightly different.<\/p> <\/p> 2<\/sup>Prescriptions are written on a prescription form known as an FP10. Each single item written on the form is counted as a prescription item.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2017-11-03", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/777814/answer/previousversion/20077", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
}
, "questionFirstAnswered" : [{"_value" : "2017-11-03T14:32:18.987Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2017-12-12T13:55:12.54Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-10-25", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Prescription Drugs: Prices"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, which prescription drugs had the highest increase in price to the NHS in the last 10 years for which data is available.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/534", "label" : {"_value" : "Biography information for Chris Ruane"}
}
, "tablingMemberConstituency" : {"_value" : "Vale of Clwyd"}
, "tablingMemberPrinted" : [{"_value" : "Chris Ruane"}
], "uin" : "109619"}
, {"_about" : "http://data.parliament.uk/resources/776154", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/776154/answer", "answerText" : {"_value" : " NHS Digital data shows that the number of National Health Service staff (full-time equivalent) working in Mental Health and Learning Disability trusts increased by 4,295 from July 2013 to July 2017, of these 2,156 are professionally qualified clinical mental health staff. The number of Improving Access to Psychological Therapies (IAPT) staff (headcount) increased by <\/p> Figures begin in 2012/13 due to the changes in services resulting from the dissolution of primary care trusts in 2012/13.<\/p> Source:<\/p> 1. Health Education England (July 2017). Stepping forward to 2020/21: The mental health workforce plan for England.<\/p> https://www.hee.nhs.uk/sites/default/files/documents/CCS0717505185-1_FYFV%20Mental%20health%20workforce%20plan%20for%20England_v5%283%29.pdf<\/a><\/p> 2. NHS Digital, Monthly workforce statistics as at July.<\/p> https://digital.nhs.uk/catalogue/PUB30100<\/a><\/p> 3. 2012 IAPT Workforce Census paragraph 5.1.<\/p> https://www.uea.ac.uk/documents/246046/11919343/iapt-workforce-education-and-training-2012-census-report.pdf/907e15d0-b36a-432c-8058-b2452d3628de<\/a><\/p> 4. The overall IAPT workforce number from the 2015 census was calculated as follows: sum of Low Intensity Therapy: Total Number of individuals (Staff in Post) on page 17 and High Intensity Therapy (HIT): Total Number of individuals (Staff in Post) on page 21. The 2015 IAPT workforce census is available at the following link:<\/p>73.65%<\/del> of hospital trusts who responded to this survey (109 <\/del> 107<\/ins>out of 148 trusts) stated that IR was available for these patients seven days a week.<\/p>For unbranded generics the Government relies on completion to keep prices down which generally works well and has led to low prices of these medicines. We alert the Competition and Markets Authority (CMA) when we believe that competition does not work. In the case of liothyronine, the CMA is currently investigating Concordia\u2019s potential abuse of its dominant position to overcharge the National Health Service for liothyronine.<\/del><\/p>In primary care community pharmacies are incentivised to source products at the lowest possible cost by allowing them to retain the medicines margin (the difference between what the NHS reimburses a pharmacy for a product and how much the pharmacy purchases it for) up to £800 million in England. In secondary care, competitive tenders ensure value-for-money to the NHS.<\/del><\/p>follows<\/del>. Any payment to ASH in respect of activity for 2017-18 will depend upon the outcome of a competitive process to secure support for delivery of the Tobacco Control Plan. <\/ins>The Department\u2019s financial records do not provide the level of detail to confirm whether funding was made under the legal power Section 64 of the Health and Public Services Act 1968 for all of this period. However, local records can confirm only<\/ins> Section 64 has been used since the financial year 2012/13.<\/p>2020<\/del>.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2017-11-03", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/778216/answer/previousversion/19960", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
}
, "questionFirstAnswered" : [{"_value" : "2017-11-03T11:41:50.29Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2018-03-21T13:09:21.407Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-10-26", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Tobacco: Packaging"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what recent assessment he has made of the effect of the introduction of plain cigarette packaging on smoking rates.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4613", "label" : {"_value" : "Biography information for Alex Burghart"}
}
, "tablingMemberConstituency" : {"_value" : "Brentwood and Ongar"}
, "tablingMemberPrinted" : [{"_value" : "Alex Burghart"}
], "uin" : "110024"}
, {"_about" : "http://data.parliament.uk/resources/777814", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/777814/answer", "answerText" : {"_value" : "and chemicals<\/del> that have shown the highest increase in cost<\/ins> price <\/del> over the last 10 years for Net Ingredient Cost (NIC) per prescription item and NIC per quantity<\/del>. Prescription medicines/chemicals<\/del> have only been included where there was prescribing in both 2006 and 2016.<\/p>2,278<\/del> 2,728 <\/ins>between 2012 and 2015.<\/p>